Role of Inflammation in Diabetic Retinopathy
Open accessThe DOI matches its Crossref record; 248 of the 249 references it cites were found in a registry or an index.
Abstract
Diabetic retinopathy is a common complication of diabetes and remains the leading cause of blindness among the working-age population. For decades, diabetic retinopathy was considered only a microvascular complication, but the retinal microvasculature is intimately associated with and governed by neurons and glia, which are affected even prior to clinically detectable vascular lesions. While progress has been made to improve the vascular alterations, there is still no treatment to counteract the early neuro-glial perturbations in diabetic retinopathy. Diabetes is a complex metabolic disorder, characterized by chronic hyperglycemia along with dyslipidemia, hypoinsulinemia and hypertension. Increasing evidence points to inflammation as one key player in diabetes-associated retinal perturbations, however, the exact underlying molecular mechanisms are not yet fully understood. Interlinked molecular pathways, such as oxidative stress, formation of advanced glycation end-products and increased expression of vascular endothelial growth factor have received a lot of attention as they all contribute to the inflammatory response. In the current review, we focus on the involvement of inflammation in the pathophysiology of diabetic retinopathy with special emphasis on the functional relationships between glial cells and neurons. Finally, we summarize recent advances using novel targets to inhibit inflammation in diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and this might explain the difference in rates of intraocular inflammation between eyes with diabetic retinopathy and those with AMD, despite being treated with the same vector and concentration.”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inflammatory processes are known to be integral in the pathogenesis of diabetic retinopathy,82”
From Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses (2022) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rajamani, U., & Jialal, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/790902 · Cited by 114
RetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Wh n ot resolved in a timely fashion the typically b nefici l eff ct of inflammation is lost a d dramatic consequence ensues [43].”
Background(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Toll-Like Receptor Signaling Pathways
Kawasaki, T., & Kawai, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00461 · Cited by 3,233
Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961
Matrix metalloproteinases as modulators of inflammation and innate immunity
Parks, W. C., Wilson, C. L., & López-Boado, Y. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1418 · Cited by 1,929
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J. L., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Müller cells in the healthy and diseased retina
BRINGMANN, A., PANNICKE, T., GROSCHE, J., FRANCKE, M., WIEDEMANN, P., SKATCHKOV, S., OSBORNE, N., & REICHENBACH, A. (2006) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.05.003 · Cited by 1,711
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
van Kooten, C., & Banchereau, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.2 · Cited by 1,404
Barber, A. J., Lieth, E., Khin, S. A., Antonetti, D. A., Buchanan, A. G., & Gardner, T. W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2425 · Cited by 1,295 · cited 1×
“While retinal ganglion cells (RGCs) are the earliest cells affected and have the highest rate of apoptosis [24,25].”
BackgroundOrkand, R. K., Nicholls, J. G., & Kuffler, S. W. (1966) · Journal of Neurophysiology · doi:10.1152/jn.1966.29.4.788 · Cited by 1,210
Prevalence of Diabetic Retinopathy in the United States, 2005-2008
Zhang, X., Saaddine, J. B., Chou, C.-F., Cotch, M. F., Cheng, Y. J., Geiss, L. S., Gregg, E. W., Albright, A. L., Klein, B. E. K., & Klein, R. (2010) · JAMA · doi:10.1001/jama.2010.1111 · Cited by 1,196
A central role for inflammation in the pathogenesis of diabetic retinopathy
Joussen, A. M., Poulaki, V., Le, M. L., Koizumi, K., Esser, C., Janicki, H., Schraermeyer, U., Kociok, N., Fauser, S., Kirchhof, B., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1476fje · Cited by 1,176
Microglia: new roles for the synaptic stripper
Kettenmann, H., Kirchhoff, F., & Verkhratsky, A. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.023 · Cited by 1,173
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
The Prevalence of Diabetic Retinopathy Among Adults in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.552 · Cited by 1,148
Extracellular matrix remodelling: the role of matrix metalloproteinases
Stamenkovic, I. (2003) · The Journal of Pathology · doi:10.1002/path.1400 · Cited by 1,140
Inflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045 · cited 1×
“Inflammati normally resolves pro ptly through a coordinated program that includes resolvins, lipoxins and protectins [42].”
BackgroundIL-1 is required for tumor invasiveness and angiogenesis
Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., Dinarello, C. A., & Apte, R. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437939100 · Cited by 1,023
Minocycline: Far beyond an Antibiotic
Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
Miller, J. W., Adamis, A. P., Shima, D. T., D'Amore, P. A., Moulton, R. S., O'Reilly, M. S., Folkman, J., Dvorak, H. F., Brown, L. F., & Berse, B. (1994) · PubMed · Cited by 810
Renal and retinal effects of enalapril and losartan in type 1 diabetes
Mauer, M., Zinman, B., Gardiner, R., Suissa, S., Sinaiko, A., Strand, T., Drummond, K., Donnelly, S., Goodyer, P., Gubler, M. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808400 · Cited by 791
Miyamoto, K., Khosrof, S., Bursell, S.-E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura, Y., & Adamis, A. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10836 · Cited by 788
The Müller cell: a functional element of the retina
Newman, E., & Reichenbach, A. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10040-0 · Cited by 788
Bringmann, A., Iandiev, I., Pannicke, T., Wurm, A., Hollborn, M., Wiedemann, P., Osborne, N. N., & Reichenbach, A. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.07.001 · Cited by 761
Antonetti, D. A., Barber, A. J., Bronson, S. K., Freeman, W. M., Gardner, T. W., Jefferson, L. S., Kester, M., Kimball, S. R., Krady, J. K., LaNoue, K. F., et al. (2006) · Diabetes · doi:10.2337/db05-1635 · Cited by 746
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells
Fiuza, C., Bustin, M., Talwar, S., Tropea, M., Gerstenberger, E., Shelhamer, J. H., & Suffredini, A. F. (2003) · Blood · doi:10.1182/blood-2002-05-1300 · Cited by 737
Overview of Epidemiologic Studies of Diabetic Retinopathy
Kobrin Klein, B. E. (2007) · Ophthalmic Epidemiology · doi:10.1080/09286580701396720 · Cited by 734 · cited 1×
“Diabetic retinopathy (DR) is the primary cause of visual impairment in the working-age population of the Western world [1].”
BackgroundMechanisms of macular edema: Beyond the surface
Daruich, A., Matet, A., Moulin, A., Kowalczuk, L., Nicolas, M., Sellam, A., Rothschild, P.-R., Omri, S., Gélizé, E., Jonet, L., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.006 · Cited by 708 · cited 2×
“While for diabetes the breakdown of the inner blood retinal barrier (BRB) is believed to play a dominant role in vascular leakage [5,6], an important role of the outer BRB has recently gained momentum (for review [7]).”
BackgroundRetinal angiogenesis in development and disease
Gariano, R. F., & Gardner, T. W. (2005) · Nature · doi:10.1038/nature04482 · Cited by 705
The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes
King, P., Peacock, I., & Donnelly, R. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00092.x · Cited by 695
The dual role of astrocyte activation and reactive gliosis
Pekny, M., Wilhelmsson, U., & Pekna, M. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.071 · Cited by 670
Glial Cells Dilate and Constrict Blood Vessels: A Mechanism of Neurovascular Coupling
Metea, M. R., & Newman, E. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4048-05.2006 · Cited by 638
Kern, T. S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/95103 · Cited by 614
Jw, M. (1994) · UCL Discovery (University College London) · Cited by 584
Glial reactivity, an early feature of diabetic retinopathy.
Rungger‐Brändle, E., Dosso, A., & Leuenberger, P. (2000) · PubMed · Cited by 581
Sun, J. K., Lin, M. M., Lammer, J., Prager, S., Sarangi, R., Silva, P. S., & Aiello, L. P. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.2350 · Cited by 574 · cited 1×
“When invading pathogens are involved, they are recognized by pattern recognition receptors, such as T ll-li e r c t rs ( s) the r ceptor f a anced glycation end pr t [36].”
BackgroundNonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
M. Joussen, A., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Döhmen, S., & P. Adamis, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0707fje · Cited by 567
Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina
Joussen, A. M., Murata, T., Tsujikawa, A., Kirchhof, B., Bursell, S.-E., & Adamis, A. P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63952-1 · Cited by 567 · cited 2×
“alterations in animal models of diabetes [19].”
BackgroundLachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Retinal microglia: Just bystander or target for therapy?
Karlstetter, M., Scholz, R., Rutar, M., Wong, W. T., Provis, J. M., & Langmann, T. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.11.004 · Cited by 551
Krady, J. K., Basu, A., Allen, C. M., Xu, Y., LaNoue, K. F., Gardner, T. W., & Levison, S. W. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1559 · Cited by 529 · cited 2×
“Studies using anti-inflammatory agents such as salicylates or minocycline in patients with DR gave further evidence that regulating the inflammatory response can be beneficial to prevent irreversible vascular and neuronal perturbations over time [20,21].”
Backgroundvan Beijnum, J. R., Buurman, W. A., & Griffioen, A. W. (2008) · Angiogenesis · doi:10.1007/s10456-008-9093-5 · Cited by 527
Microglia activation in retinal degeneration
Langmann, T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207114 · Cited by 496 · cited 1×
“Consequently, the resident immune cells in the retina, called microglia, also become activated and start to produce pro-inflammatory mediators, exacerbating neuro-glial and vascular dysfunction [31].”
BackgroundMüller cell changes in human diabetic retinopathy.
Mizutani, M., Gerhardinger, C., & Lorenzi, M. (1998) · Diabetes · doi:10.2337/diabetes.47.3.445 · Cited by 481 · cited 12×
“Hypoxia-activated macrophages, glial cells and microglia cells produce TNF-α and IL-6 and other inflammatory cytokines and growth factors, which in turn stimulate further release of MCP-1, IL-6 and VEGF by endothelial cells, potentially resulting in increased vascular permeability as seen in NPDR and DME [21,110].”
BackgroundInfluentialAgemy, S. A., Scripsema, N. K., Shah, C. M., Chui, T., Garcia, P. M., Lee, J. G., Gentile, R. C., Hsiao, Y.-S., Zhou, Q., Ko, T., et al. (2015) · Retina · doi:10.1097/iae.0000000000000862 · Cited by 472 · cited 1×
“The latest progress in this domain is the technique of OCT angiography, which permits to combine with the anatomical observation the non-invasive study of the different layers of retinal microvasculature and choroid circulation via motion contrast imaging [39].”
MethodAssociation of Vitreous Inflammatory Factors with Diabetic Macular Edema
Funatsu, H., Noma, H., Mimura, T., Eguchi, S., & Hori, S. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.09.037 · Cited by 451 · cited 1×
“In patients with DME, levels of angiopoietin-2 (Ang-2), an important modulator of angiogenesis, are significantly elevated along with inflammatory cytokines and VEGF [12,58].”
BackgroundSjølie, A. K., Klein, R., Porta, M., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Chaturvedi, N. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61411-7 · Cited by 435
Retinal ganglion cells in diabetes
Kern, T. S., & Barber, A. J. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.156695 · Cited by 422 · cited 1×
“While retinal ganglion cells (RGCs) are the earliest cells affected and have the highest rate of apoptosis [24,25].”
BackgroundMicroglial Activation in Human Diabetic Retinopathy
Zeng, H.-Y. (2008) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2007.65 · Cited by 402
Cuenca, N., Fernández-Sánchez, L., Campello, L., Maneu, V., De la Villa, P., Lax, P., & Pinilla, I. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.07.001 · Cited by 401
Demircan, N., Safran, B. G., Soylu, M., Ozcan, A. A., & Sizmaz, S. (2006) · Eye · doi:10.1038/sj.eye.6702138 · Cited by 395 · cited 1×
“Some of the cytokines identified, such as MIP-1, IL-1 and IL-3, are thought to also have a role in angiogenesis, as established in experimental ischemic mouse models suggesting that inflammation also contributes and precedes the development of neovascularization in PDR [21,53,54].”
BackgroundJoussen, A. M., Poulaki, V., Qin, W., Kirchhof, B., Mitsiades, N., Wiegand, S. J., Rudge, J., Yancopoulos, G. D., & Adamis, A. P. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64869-9 · Cited by 392
Role of microglia in CNS inflammation
Graeber, M. B., Li, W., & Rodriguez, M. L. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.033 · Cited by 392
Nonsteroidal Anti-inflammatory Drugs in Ophthalmology
Kim, S. J., Flach, A. J., & Jampol, L. M. (2010) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2009.07.005 · Cited by 383
Vascular endothelial growth factor: a neurovascular target in neurological diseases
Lange, C., Storkebaum, E., de Almodóvar, C. R., Dewerchin, M., & Carmeliet, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.88 · Cited by 382
Retinal neurodegeneration: early pathology in diabetes
Lieth, E., Gardner, T. W., Barber, A. J., & Antonetti, D. A. (2000) · Clinical & Experimental Ophthalmology · doi:10.1046/j.1442-9071.2000.00222.x · Cited by 360 · cited 1×
“Several excellent reviews published in the last decade have summarized the evidence that neurons are vulnerable and die early in diabetic retinopathy, however, the pathophysiological mechanisms underlying this neurodegenerative process remain to be clearly elucidated [22,23].”
BackgroundCellular forms and functions of brain microglia
Davis, E. J., Foster, T. D., & Thomas, W. E. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90189-9 · Cited by 358
Ulbrich, H., Eriksson, E. E., & Lindbom, L. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.10.004 · Cited by 354
Pathogenesis of Diabetic Retinopathy
Engerman, R. L. (1989) · Diabetes · doi:10.2337/diab.38.10.1203 · Cited by 353
Is diabetic retinopathy an inflammatory disease?
Adamis, A. P. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.4.363 · Cited by 341
Neuron–glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
Sheridan, G. K., & Murphy, K. J. (2013) · Open Biology · doi:10.1098/rsob.130181 · Cited by 337
Du, Y., Veenstra, A., Palczewski, K., & Kern, T. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314575110 · Cited by 335
High mobility group 1 B‐box mediates activation of human endothelium
Treutiger, C. J., Mullins, G. E., Johansson, A. ‐. M., Rouhiainen, A., Rauvala, H. M. E., Erlandsson‐Harris, H., Andersson, U., Yang, H., Tracey, K. J., Andersson, J., et al. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01204.x · Cited by 332
Giebel, S. J., Menicucci, G., McGuire, P. G., & Das, A. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700251 · Cited by 325 · cited 1×
“Matrix metalloproteinases (MMPs), which are important regulators of those migratory and tissue remodeling events, have been reported to be upregulated in PDR as well [57].”
BackgroundApoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina
Park, S.-H., Park, J.-W., Park, S.-J., Kim, K.-Y., Chung, J.-W., Chun, M.-H., & Oh, S.-J. (2003) · Diabetologia · doi:10.1007/s00125-003-1177-6 · Cited by 322 · cited 1×
“An elevated rate of apoptosis has been also observed in the outer nuclear layer, with a reduction in photoreceptors seen between 4 and 24 weeks after diabetes onset [26,27].”
BackgroundBusik, J. V., Mohr, S., & Grant, M. B. (2008) · Diabetes · doi:10.2337/db07-1520 · Cited by 312
Contrast Sensitivity in Diabetics With and Without Background Retinopathy
Sokol, S., Moskowitz, A., Skarf, B., Evans, R., Molitch, M., & Senior, B. (1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050010055018 · Cited by 302 · cited 1×
“Other less cellular specific alterations have also been reported including abnormal dark adaptation, contrast sensitivity [34] and color vision [35].”
BackgroundMiller, J. W., Adamis, A. P., Shima, D. T., DʼAmore, P. A., Moulton, R. S., OʼReilly, M. S., Folkman, J., Dvorak, H. F., Brown, L. F., & Berse, B. (1995) · Retina · doi:10.1097/00006982-199515020-00021 · Cited by 297 · cited 1×
“The ability of vascular endothelial growth factor (VEGF) to promote both vascular permeability and angiogenesis made it a likely contributor to the vascular dysfunctions observed in severe DR [8,9].”
BackgroundDoganay, S., Evereklioglu, C., Er, H., Türköz, Y., Sevinç, A., Mehmet, N., & Şavli, H. (2002) · Eye · doi:10.1038/sj.eye.6700095 · Cited by 294
Expression of Apoptosis Markers in the Retinas of Human Subjects with Diabetes
El-Asrar, A. M. A., Dralands, L., Missotten, L., Al-Jadaan, I. A., & Geboes, K. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-1392 · Cited by 292 · cited 12×
“Hypoxia-activated macrophages, glial cells and microglia cells produce TNF-α and IL-6 and other inflammatory cytokines and growth factors, which in turn stimulate further release of MCP-1, IL-6 and VEGF by endothelial cells, potentially resulting in increased vascular permeability as seen in NPDR and DME [21,110].”
BackgroundInfluentialBarber, A. J., Nakamura, M., Wolpert, E. B., Reiter, C. E. N., Seigel, G. M., Antonetti, D. A., & Gardner, T. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104738200 · Cited by 288
Serum Inflammatory Markers in Diabetic Retinopathy
Meleth, A. D., Agro´n, E., Chan, C.-C., Reed, G. F., Arora, K., Byrnes, G., Csaky, K. G., Ferris, F. L., & Chew, E. Y. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1057 · Cited by 283
Tsutsumi, C., Sonoda, K.-H., Egashira, K., Qiao, H., Hisatomi, T., Nakao, S., Ishibashi, M., Charo, I. F., Sakamoto, T., Murata, T., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0902436 · Cited by 277
Microglia Versus Myeloid Cell Nomenclature during Brain Inflammation
Greter, M., Lelios, I., & Croxford, A. L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00249 · Cited by 273
CD40 and autoimmunity: The dark side of a great activator
Peters, A. L., Stunz, L. L., & Bishop, G. A. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.012 · Cited by 270
Grant, M., Russell, B., Fitzgerald, C., & Merimee, T. J. (1986) · Diabetes · doi:10.2337/diab.35.4.416 · Cited by 268
Iwaki, T., Wısnıewskı, T., Iwaki, A., Corbin, E., Tomokane, N., Tateishi, J., & Goldman, J. E. (1992) · PubMed · Cited by 265
TNF-α signaling in glaucomatous neurodegeneration
Tezel, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)01128-x · Cited by 261
Expression of Acute-Phase Response Proteins in Retinal Müller Cells in Diabetes
Gerhardinger, C., Costa, M. B., Coulombe, M. C., Toth, I., Hoehn, T., & Grosu, P. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0860 · Cited by 261
Marumo, T., Schini-Kerth, V. B., & Busse, R. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1131 · Cited by 251
Tolentino, M. J., Mcleod, D. S., Taomoto, M., Otsuji, T., Adamis, A. P., & Lutty, G. A. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01381-2 · Cited by 250
Oxidative stress and diabetic retinopathy: development and treatment
Calderon, G. D., Juarez, O. H., Hernandez, G. E., Punzo, S. M., & De la Cruz, Z. D. (2017) · Eye · doi:10.1038/eye.2017.64 · Cited by 250
Gao, B.-B., Chen, X., Timothy, N., Aiello, L. P., & Feener, E. P. (2008) · Journal of Proteome Research · doi:10.1021/pr800112g · Cited by 249
Kim, J. J., & Sears, D. D. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/212563 · Cited by 248
Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence
Simó, R., & Hernández, C. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.04.003 · Cited by 239
Microglia function during brain development: New insights from animal models
Bilimoria, P. M., & Stevens, B. (2015) · Brain Research · doi:10.1016/j.brainres.2014.11.032 · Cited by 237
Ogata, N., Nishikawa, M., Nishimura, T., Mitsuma, Y., & Matsumura, M. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01568-4 · Cited by 234
Diabetic macular edema: new concepts in patho-physiology and treatment
Zhang, X., Zeng, H., Bao, S., Wang, N., & Gillies, M. C. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-27 · Cited by 230 · cited 2×
“While for diabetes the breakdown of the inner blood retinal barrier (BRB) is believed to play a dominant role in vascular leakage [5,6], an important role of the outer BRB has recently gained momentum (for review [7]).”
BackgroundDiabetic retinopathy and inflammation: Novel therapeutic targets
Das, A., Rangasamy, S., & McGuire, P. (2012) · Middle East African Journal of Ophthalmology · doi:10.4103/0974-9233.92116 · Cited by 228
Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy
Elner, S. G., Elner, V. M., Jaffe, G. J., Stuart, A., Kunkel, S. L., & Strieter, R. M. (1995) · Current Eye Research · doi:10.3109/02713689508998529 · Cited by 228
Zheng, L., Du, Y., Miller, C., Gubitosi-Klug, R. A., Kern, T. S., Ball, S., & Berkowitz, B. A. (2007) · Diabetologia · doi:10.1007/s00125-007-0734-9 · Cited by 224
Meyer-Schwickerath, R., Pfeiffer, A., Blum, W. F., Freyberger, H., Klein, M., Lösche, C., Röllmann, R., & Schatz, H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116877 · Cited by 224
Expression of αB-crystallin in Alzheimer's disease
Renkawek, K., Voorter, C. E. M., Bosman, G. J. C. G. M., van Workum, F. P. A., & de Jong, W. W. (1994) · Acta Neuropathologica · doi:10.1007/bf00296185 · Cited by 222
Blood-neural Barrier: Intercellular Communication at Glio-Vascular Interface
Kim, J.-H., Kim, J.-H., Park, J.-A., Lee, S.-W., Kim, W.-J., Yu, Y.-S., & Kim, K.-W. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.4.339 · Cited by 218
Sivalingam, A. (1990) · Archives of Ophthalmology · doi:10.1001/archopht.1990.01070080113046 · Cited by 218
Control of autoimmune CNS inflammation by astrocytes
Rothhammer, V., & Quintana, F. J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0515-3 · Cited by 214
Proteolytic Degradation of VE-Cadherin Alters the Blood-Retinal Barrier in Diabetes
Navaratna, D., McGuire, P. G., Menicucci, G., & Das, A. (2007) · Diabetes · doi:10.2337/db06-1694 · Cited by 211
FUNATSU, H., YAMASHITA, H., SAKATA, K., NOMA, H., MIMURA, T., SUZUKI, M., EGUCHI, S., & HORI, S. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.11.045 · Cited by 209
Early cellular and molecular changes induced by diabetes in the retina
Lorenzi, M., & Gerhardinger, C. (2001) · Diabetologia · doi:10.1007/s001250100544 · Cited by 205 · cited 1×
“Several excellent reviews published in the last decade have summarized the evidence that neurons are vulnerable and die early in diabetic retinopathy, however, the pathophysiological mechanisms underlying this neurodegenerative process remain to be clearly elucidated [22,23].”
BackgroundNeuroprotection by tetracyclines
Domercq, M., & Matute, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.001 · Cited by 205
Doğanay, S., Evereklioğlu, C., Er, H., et al. (2002) · Eye · doi:10.1038/sj/eye/6700095 · Cited by 203
Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes
Valle, A., Giamporcaro, G. M., Scavini, M., Stabilini, A., Grogan, P., Bianconi, E., Sebastiani, G., Masini, M., Maugeri, N., Porretti, L., et al. (2013) · Diabetes · doi:10.2337/db12-1345 · Cited by 202
Zong, H., Ward, M., Madden, A., Yong, P. H., Limb, G. A., Curtis, T. M., & Stitt, A. W. (2010) · Diabetologia · doi:10.1007/s00125-010-1900-z · Cited by 201
Boss, J. D., Singh, P. K., Pandya, H. K., Tosi, J., Kim, C., Tewari, A., Juzych, M. S., Abrams, G. W., & Kumar, A. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-21973 · Cited by 200 · cited 3×
“Significantly higher vitreous levels of neurotrophins (NTs), a group of specific growth factors, such as nerve growth factor (NGF), brain-derived neurotrophic factor (BNDF), NT-3, NT-4, ciliary neurotrophic factor (CNTF) and glial cell line-derived neurotrophic factor (GNDF) could be detected in DR patients, with even…”
BackgroundResultMicrovascular Modifications in Diabetic Retinopathy
Durham, J. T., & Herman, I. M. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0204-0 · Cited by 198
Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma
Steele, M. R., Inman, D. M., Calkins, D. J., Horner, P. J., & Vetter, M. L. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0865 · Cited by 196
Association between photoreceptor integrity and visual outcome in diabetic macular edema
Shin, H. J., Lee, S. H., Chung, H., & Kim, H. C. (2012) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1774-x · Cited by 196
The Role of Microglia in Diabetic Retinopathy
Grigsby, J. G., Cardona, S. M., Pouw, C. E., Muniz, A., Mendiola, A. S., Tsin, A. T. C., Allen, D. M., & Cardona, A. E. (2014) · Journal of Ophthalmology · doi:10.1155/2014/705783 · Cited by 196
Seki, M., Tanaka, T., Nawa, H., Usui, T., Fukuchi, T., Ikeda, K., Abe, H., & Takei, N. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2412 · Cited by 193
Nitrogen shuttling between neurons and glial cells during glutamate synthesis
Lieth, E., LaNoue, K. F., Berkich, D. A., Xu, B., Ratz, M., Taylor, C., & Hutson, S. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00156.x · Cited by 192
Ibrahim, A. S., El-Remessy, A. B., Matragoon, S., Zhang, W., Patel, Y., Khan, S., Al-Gayyar, M. M., El-Shishtawy, M. M., & Liou, G. I. (2011) · Diabetes · doi:10.2337/db10-1160 · Cited by 190
Lee, T.-H., Avraham, H., Lee, S.-H., & Avraham, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107348200 · Cited by 185
VEGF-mediated inflammation precedes angiogenesis in adult brain
CROLL, S. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.02.010 · Cited by 184
Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
Gilbert, R. E., Vranes, D., Wilkinson‐Berka, J. L., Kelly, D. J., Cox, A. J., Wu, L. L., Stacker, S. A., & Cooper, M. E. (1998) · PubMed · Cited by 179
Kern, T. S., Miller, C. M., Du, Y., Zheng, L., Mohr, S., Ball, S. L., Kim, M., Jamison, J. A., & Bingaman, D. P. (2007) · Diabetes · doi:10.2337/db05-1621 · Cited by 177
Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy
Zheng, L., Howell, S. J., Hatala, D. A., Huang, K., & Kern, T. S. (2007) · Diabetes · doi:10.2337/db06-0789 · Cited by 176
Color Vision Defects in Early Diabetic Retinopathy
Roy, M. S., Gunkel, R. D., & Podgor, M. J. (1986) · Archives of Ophthalmology · doi:10.1001/archopht.1986.01050140079024 · Cited by 175 · cited 1×
“Other less cellular specific alterations have also been reported including abnormal dark adaptation, contrast sensitivity [34] and color vision [35].”
BackgroundDu, Y., Sarthy, V. P., & Kern, T. S. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00080.2003 · Cited by 169
FUNATSU, H., YAMASHITA, H., NAKAMURA, S., MIMURA, T., EGUCHI, S., NOMA, H., & HORI, S. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.030 · Cited by 168
García-Ramírez, M., Canals, F., Hernández, C., Colomé, N., Ferrer, C., Carrasco, E., García-Arumí, J., & Simó, R. (2007) · Diabetologia · doi:10.1007/s00125-007-0627-y · Cited by 167
Yoshida, S., Yoshida, A., Ishibashi, T., Elner, S. G., & Elner, V. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0302117 · Cited by 166 · cited 1×
“Some of the cytokines identified, such as MIP-1, IL-1 and IL-3, are thought to also have a role in angiogenesis, as established in experimental ischemic mouse models suggesting that inflammation also contributes and precedes the development of neovascularization in PDR [21,53,54].”
BackgroundYoshida, S., Yoshida, A., & Ishibashi, T. (2004) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-004-0874-2 · Cited by 166
Sorrentino, F. S., Allkabes, M., Salsini, G., Bonifazzi, C., & Perri, P. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.08.001 · Cited by 166
Amrite, A. C., Ayalasomayajula, S. P., Cheruvu, N. P. S., & Kompella, U. B. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0531 · Cited by 162
Baicalein Reduces Inflammatory Process in a Rodent Model of Diabetic Retinopathy
Yang, L.-P., Sun, H.-L., Wu, L.-M., Guo, X.-J., Dou, H.-L., Tso, M. O. M., Zhao, L., & Li, S.-M. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2642 · Cited by 162
Cyclooxygenase-2 in Human and Experimental Ischemic Proliferative Retinopathy
Sennlaub, F., Valamanesh, F., Vazquez-Tello, A., El-Asrar, A. M., Checchin, D., Brault, S., Gobeil, F., Beauchamp, M. H., Mwaikambo, B., Courtois, Y., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080735.93327.00 · Cited by 161
Verma, A., Rani, P. K., Raman, R., Pal, S. S., Laxmi, G., Gupta, M., Sahu, C., Vaitheeswaran, K., & Sharma, T. (2009) · Eye · doi:10.1038/eye.2009.184 · Cited by 160 · cited 1×
“Among those functional changes are deficits pointing to ganglion cells such as the pattern electroretinogram (ERG), altered microperimetric [32] and perimetric testing [11]; or more generally the inner retina such as increased implicit times and reduction in oscillatory potentials in the multifocal ERG (mfERG) [33].”
BackgroundAyalasomayajula, S. P., & Kompella, U. B. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02793-0 · Cited by 159
Chen, W., Esselman, W. J., Jump, D. B., & Busik, J. V. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0601 · Cited by 158
DIABETIC RETINOPATHY AND RHEUMATOID ARTHRITIS
Powell, E. D. U., & Field, R. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90008-x · Cited by 157 · cited 1×
“Studies using anti-inflammatory agents such as salicylates or minocycline in patients with DR gave further evidence that regulating the inflammatory response can be beneficial to prevent irreversible vascular and neuronal perturbations over time [20,21].”
BackgroundCusick, M., Chew, E. Y., Chan, C., Kruth, H. S., Murphy, R. P., & Ferris, F. L. (2003) · Ophthalmology · doi:10.1016/j.ophtha.2003.01.001 · Cited by 156
Intravitreal Steroids for Macular Edema: The Past, the Present, and the Future
Cunningham, M. A., Edelman, J. L., & Kaushal, S. (2008) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2007.12.005 · Cited by 153
Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
El‐Asrar, A. M. A., Struyf, S., Kangave, D., Geboes, K. J., & Damme, J. V. (2006) · PubMed · Cited by 152
Zhang, J., Gerhardinger, C., & Lorenzi, M. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3499 · Cited by 151
Sax, C. M., & Piatigorsky, J. (1994) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470123157.ch5 · Cited by 150
Duh, E. J., Yang, H. S., Haller, J. A., de Juan, E., Humayun, M. S., Gehlbach, P. L., Melia, M., Pieramici, D. J., Harlan, J. B., Campochiaro, P. A., et al. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.015 · Cited by 146
Interleukin‐1β: a bridge between inflammation and excitotoxicity?
Fogal, B., & Hewett, S. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05315.x · Cited by 145
Lee, C. Z., Xue, Z., Zhu, Y., Yang, G., & Young, W. L. (2007) · Stroke · doi:10.1161/strokeaha.106.481515 · Cited by 145
Effects of Aspirin Treatment on Diabetic Retionopathy
* (1991) · Ophthalmology · doi:10.1016/s0161-6420(13)38010-5 · Cited by 145
Eastlake, K., Banerjee, P. J., Angbohang, A., Charteris, D. G., Khaw, P. T., & Limb, G. A. (2016) · Glia · doi:10.1002/glia.22942 · Cited by 142
CYTOKINE CONCENTRATION IN AQUEOUS HUMOR OF EYES WITH DIABETIC MACULAR EDEMA
Jonas, J. B., Jonas, R. A., Neumaier, M., & Findeisen, P. (2011) · Retina · doi:10.1097/iae.0b013e3182576d07 · Cited by 137
Alterations to the Blood–Retinal Barrier in Diabetes: Cytokines and Reactive Oxygen Species
Frey, T., & Antonetti, D. A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3906 · Cited by 137 · cited 2×
“While for diabetes the breakdown of the inner blood retinal barrier (BRB) is believed to play a dominant role in vascular leakage [5,6], an important role of the outer BRB has recently gained momentum (for review [7]).”
BackgroundJain, A., Saxena, S., Khanna, V. K., Shukla, R. K., & Meyer, C. H. (2013) · PubMed Central · Cited by 137
Targeted Disruption of the CD18 or ICAM-1 Gene Inhibits Choroidal Neovascularization
Sakurai, E., Taguchi, H., Anand, A., Ambati, B. K., Gragoudas, E. S., Miller, J. W., Adamis, A. P., & Ambati, J. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1246 · Cited by 134
Photoreceptors in diabetic retinopathy
Kern, T. S., & Berkowitz, B. A. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12312 · Cited by 133
Holm, T. H., Draeby, D., & Owens, T. (2012) · Glia · doi:10.1002/glia.22296 · Cited by 131
Retinal fibrosis in diabetic retinopathy
Roy, S., Amin, S., & Roy, S. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.04.004 · Cited by 129
The role of glia in retinal vascular disease
Coorey, N. J., Shen, W., Chung, S. H., Zhu, L., & Gillies, M. C. (2012) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2012.00741.x · Cited by 128
Cassidy, L., Barry, P., Shaw, C., Duffy, M. J., & Kennedy, S. (1998) · British Journal of Ophthalmology · doi:10.1136/bjo.82.2.181 · Cited by 128
Wang, X., Wang, G., & Wang, Y. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.07.007 · Cited by 128
Association between Aqueous Cytokines and Diabetic Retinopathy Stage
Wu, H., Hwang, D., Song, X., & Tao, Y. K. (2017) · Journal of Ophthalmology · doi:10.1155/2017/9402198 · Cited by 127 · cited 1×
“The increase in these cytokines produced by activated microglia, endothelial cells, macroglia, and later even neurons, highlight the increased activity of these inflammatory cytokines in the early stages of DR and the progression of the inflammatory response throughout all cell types of the retina [52].”
BackgroundOsteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis
Leali, D., Dell’Era, P., Stabile, H., Sennino, B., Chambers, A. F., Naldini, A., Sozzani, S., Nico, B., Ribatti, D., & Presta, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.1085 · Cited by 126
Portillo, J.-A. C., Lopez Corcino, Y., Miao, Y., Tang, J., Sheibani, N., Kern, T. S., Dubyak, G. R., & Subauste, C. S. (2017) · Diabetes · doi:10.2337/db16-0051 · Cited by 126
Vallejo, S., Rosas, E. P., Romacho, T., Villalobos, L. A., Peiró, C., & Sánchez‐Ferrer, C. F. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0158-z · Cited by 125
TNF-Alpha Levels in Tears: A Novel Biomarker to Assess the Degree of Diabetic Retinopathy
Costagliola, C., Romano, V., Tollis, M. D., Aceto, F., dell’Omo, R., Romano, M. R., Pedicino, C., & Semeraro, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/629529 · Cited by 124
Reactive changes of retinal astrocytes and Müller glial cells in kainate‐induced neuroexcitotoxicity
Chang, M., Wu, C., Jiang‐Shieh, Y., Shieh, J., & Wen, C. (2007) · Journal of Anatomy · doi:10.1111/j.1469-7580.2006.00671.x · Cited by 121
Diabetic eNOS-Knockout Mice Develop Accelerated Retinopathy
Li, Q., Verma, A., Han, P.-Y., Nakagawa, T., Johnson, R. J., Grant, M. B., Campbell‐Thompson, M., Jarajapu, Y. P. R., Lei, B., & Hauswirth, W. W. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-5147 · Cited by 120
Tang, J. C. O., Du, Y., Lee, C. A., Talahalli, R. R., Eells, J. T., & Kern, T. S. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11018 · Cited by 114
Vujosevic, S., Micera, A., Bini, S., Berton, M., Esposito, G., & Midena, E. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12812 · Cited by 113
Temporal Changes in Gene Expression after Injury in the Rat Retina
Va´zquez-Chona, F., Song, B. K., & Geisert, E. E. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-1047 · Cited by 113
Leukocyte Adhesion Molecules in Diabetic Retinopathy
Noda, K., Nakao, S., Ishida, S., & Ishibashi, T. (2012) · Journal of Ophthalmology · doi:10.1155/2012/279037 · Cited by 113
Ali, T. K., Al-Gayyar, M. M. H., Matragoon, S., Pillai, B. A., Abdelsaid, M. A., Nussbaum, J. J., & El‐Remessy, A. B. (2010) · Diabetologia · doi:10.1007/s00125-010-1935-1 · Cited by 112
Müller Glia Are a Major Cellular Source of Survival Signals for Retinal Neurons in Diabetes
Fu, S., Dong, S., Zhu, M., Sherry, D. M., Wang, C., You, Z., Haigh, J. J., & Le, Y.-Z. (2015) · Diabetes · doi:10.2337/db15-0180 · Cited by 110
Angiopoietin concentrations in diabetic retinopathy
Patel, J. I. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.049940 · Cited by 109 · cited 1×
“In patients with DME, levels of angiopoietin-2 (Ang-2), an important modulator of angiogenesis, are significantly elevated along with inflammatory cytokines and VEGF [12,58].”
BackgroundAqueous Humor Biomarkers of Müller Cell Activation in Diabetic Eyes
Vujosevic, S., Micera, A., Bini, S., Berton, M., Esposito, G., & Midena, E. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16554 · Cited by 107 · cited 1×
“Increased levels of GFAP has indeed been reported in the aqueous humor of such patients [47].”
BackgroundCukras, C. A., Petrou, P., Chew, E. Y., Meyerle, C. B., & Wong, W. T. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-9413 · Cited by 107
An Integrated Approach to Diabetic Retinopathy Research
Gardner, T. W. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.362 · Cited by 104 · cited 2×
“Among those functional changes are deficits pointing to ganglion cells such as the pattern electroretinogram (ERG), altered microperimetric [32] and perimetric testing [11]; or more generally the inner retina such as increased implicit times and reduction in oscillatory potentials in the multifocal ERG (mfERG) [33].”
BackgroundDementia with β-amyloid deposition: involvement of αB-crystallin supports two main diseases
Lowe, J. S., Landon, M., Pike, I., Spendlove, I., McDermott, H., & Mayer, R. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)92075-s · Cited by 103
Microglia and inflammation: conspiracy, controversy or control?
Fernandes, A., Miller-Fleming, L., & Pais, T. F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1670-8 · Cited by 103
Burgos, R., Simó, R., Audı́, L., Mateo, C., Mesa, J., García‐Ramírez, M., & Carrascosa, A. (1997) · Diabetologia · doi:10.1007/s001250050794 · Cited by 102
Distinct Roles for IL-4 and IL-10 in Regulating T2 Immunity during Allergic Bronchopulmonary Mycosis
Hernandez, Y., Arora, S., Erb-Downward, J. R., McDonald, R. A., Toews, G. B., & Huffnagle, G. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1027 · Cited by 101
Yngen, M., Östenson, C. ‐., Hu, H., Li, N., Hjemdahl, P., & Wallén, N. H. (2004) · Diabetologia · doi:10.1007/s00125-004-1352-4 · Cited by 101
MATRIX METALLOPROTEINASES IN HUMAN DIABETIC AND NONDIABETIC VITREOUS
Jin, M., Kashiwagi, K., IIZUKA, Y., Tanaka, Y., Imai, M., & Tsukahara, S. (2001) · Retina · doi:10.1097/00006982-200102000-00005 · Cited by 100
Lee, W. J., Kang, M. H., Seong, M., & Cho, H. Y. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-301913 · Cited by 99
Uckermann, O., Wolf, A., Kutzera, F., Kalisch, F., Beck-Sickinger, A. G., Wiedemann, P., Reichenbach, A., & Bringmann, A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20760 · Cited by 98
Takeuchi, M., Sato, T., Tanaka, A., Muraoka, T., Taguchi, M., Sakurai, Y., Karasawa, Y., & Ito, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137358 · Cited by 96
Sfikakis, P. P., Markomichelakis, N. N., THEODOSSIADIS, G. P., Grigoropoulos, V. G., Katsilambros, N., & Theodossiadis, P. G. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.445 · Cited by 92
Intense light exposure changes the crystallin content in retina
Sakaguchi, H., Miyagi, M., Darrow, R. M., Crabb, J. S., Hollyfield, J. G., Organisciak, D. T., & Crabb, J. W. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(02)00249-x · Cited by 91
Monocyte Chemotactic Protein-1 in the Vitreous of Patients with Proliferative Diabetic Retinopathy
Mitamura, Y., Takeuchi, S., Matsuda, A., Tagawa, Y., Mizue, Y., & Nishihira, J. (2001) · Ophthalmologica · doi:10.1159/000050900 · Cited by 90
Pathologic Alterations of the Outer Retina in Streptozotocin-Induced Diabetes
Énzsöly, A., Szabó, A., Kántor, O., Dávid, C., Szalay, P., Szabó, K., Szél, Á., Németh, J., & Lukáts, Á. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13562 · Cited by 89 · cited 1×
“An elevated rate of apoptosis has been also observed in the outer nuclear layer, with a reduction in photoreceptors seen between 4 and 24 weeks after diabetes onset [26,27].”
BackgroundJialal, I., & Kaur, H. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0258-7 · Cited by 89 · cited 2×
“The molecules of the pathogens that bind to these rec ptors are called pathogen-associated molecular patterns (PAMPs) [41].”
BackgroundRao, N. A., Saraswathy, S., Wu, G. S., Katselis, G. S., Wawrousek, E. F., & Bhat, S. P. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1259 · Cited by 89
Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes
Khalfaoui, T., Lizard, G., & Ouertani, A. M. (2007) · Journal of Molecular Histology · doi:10.1007/s10735-007-9159-5 · Cited by 83
Tonade, D., Liu, H., & Kern, T. S. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19859 · Cited by 83
Aplin, A. C., Gelati, M., Fogel, E., Carnevale, E., & Nicosia, R. F. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00048.2006 · Cited by 81
Cardona, S. M., Mendiola, A. S., Yang, Y.-C., Adkins, S. L., Torres, V., & Cardona, A. E. (2015) · ASN Neuro · doi:10.1177/1759091415608204 · Cited by 81
Shin, E. S., Huang, Q., Gurel, Z., Sorenson, C. M., & Sheibani, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103148 · Cited by 78
Bernardino, A. L. F., Kaushal, D., & Philipp, M. T. (2009) · The Journal of Infectious Diseases · doi:10.1086/597807 · Cited by 78
Identification of VEGF-Independent Cytokines in Proliferative Diabetic Retinopathy Vitreous
Bromberg-White, J. L., Glazer, L. C., Downer, R. G., Furge, K., Boguslawski, E. A., & Duesbery, N. S. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12518 · Cited by 78
Photobiomodulation in the treatment of patients with non-center-involving diabetic macular oedema
Tang, J. C. O., Herda, A. A., & Kern, T. S. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304477 · Cited by 77
Zhang, H. M., Trivedi, A. A., Lee, J.-U., Lohela, M. K., Lee, S. M., Fandel, T. M., Werb, Z., & Noble‐Haeusslein, L. J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3943-11.2011 · Cited by 75
Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia.
Li, G., Tang, J., Du, Y., Lee, C. A., & Kern, T. S. (2011) · PubMed Central · Cited by 73
Research works printed but not linked: 1
- (2017, October 30). Allegro Ophthalmics Announces Positive Topline Results from Del Mar Phase 2b Trial Evaluating Luminate® in Patients with Diabetic Macular Edema. Available online: http://www.allegroeye.com/press.
Cited by
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links.
Oguntibeju, O. O. (2019) · Europe PMC (PubMed Central) · Cited by 1,224
Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing
Kharaziha, M., Baidya, A., & Annabi, N. (2021) · Advanced Materials · doi:10.1002/adma.202100176 · Cited by 721
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
Eid, S., Sas, K. M., Abcouwer, S. F., Feldman, E. L., Gardner, T. W., Pennathur, S., & Fort, P. E. (2019) · Diabetologia · doi:10.1007/s00125-019-4959-1 · Cited by 468
Self-citationVEGFR1 signaling in retinal angiogenesis and microinflammation
Uemura, A., Fruttiger, M., D'Amore, P. A., De Falco, S., Joussen, A. M., Sennlaub, F., Brunck, L. R., Johnson, K. T., Lambrou, G. N., Rittenhouse, K. D., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100954 · Cited by 354
“Accordingly, the review begins by introducing the current biology of the VEGFR1 itself and in context with VEGFR2, Abbreviations AMD Age-related macular degeneration BRB Blood–retina barrier BRVO Branch retinal vein occlusion CCL2 CC chemokine ligand 2 CNV Choroidal neovascularization CRVO Central retinal vein occlusi…”
ResultInfluential
Metadata
- Authors
- Rübsam, A., Parikh, S., & Fort, P.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Fort, Patrice
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-03-22
- Volume
- 19
- Issue
- 4
- Pages
- 942
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979417
- OpenAlex
- W2793401320
- Cited by
- 750
- References
- 249
- Citations by year
- 2026: 46 · 2025: 91 · 2024: 107 · 2023: 118 · 2022: 127 · 2021: 107 · 2020: 83 · 2019: 59 · 2018: 11
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Eye Institute (R01-EY020895)
- Deutsche Forschungsgemeinschaft (RU 2020/2-1)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- diabetic retinopathy, inflammation, neuroglial interactions, retinal microvasculature, oxidative stress, advanced glycation end products, vascular endothelial growth factor, glial cells, neurons, diabetes complications
- MeSH terms
- Animals, Astrocytes, Diabetic Retinopathy, Humans, Inflammation, Neurodegenerative Diseases, Ependymoglial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.